„pragmatic, quick and secure in his judgments, specialist for complicated issues, esp. in advertising of medical products"
"... the HWG* expert..."
[*Act on the Advertising of Medical Products]
"'very good IP lawyer'"
“'is diligent and efficient, skilled in litigation and always responsive; and his advice is valuable and cost-effective'”
"His counsel comes underpinned by a rare understanding of medicine advertising"
Arne Lambrecht is a partner at HARTE-BAVENDAMM Rechtsanwälte. He advises on all legal aspects of intellectual property rights and technology with a particular focus on trademark, unfair competition and pharmaceutical advertising law as well as the drafting and negotiation of contracts.
Arne regularly represents domestic and international clients in litigious disputes pending before German and European courts as well as in trademark matters before the German PTO and EUIPO. He also provides strategic advice in preparation of or to avoid court litigation, such as in particular on legally compliant pharmaceutical advertising. In addition, Arne advises on the protection, commercialization, management and transfer of intellectual property rights, software, technologies and know-how as well as the drafting, negotiation and enforcement of related license and other agreements. Arne also has in-depth experience relative to coordinating and handling the IP and IT aspects of corporate transactions and technology projects.
Following studies of law at the University of Freiburg im Breisgau, Arne graduated with a doctoral degree in law (Dr. jur.) for his thesis on copyright protection of video games. He received his legal traineeship at the Hanseatic Higher District Court of Hamburg and was admitted to the bar in 2005. Before joining HARTE-BAVENDAMM in 2011, Arne practiced at Hengeler Mueller in Düsseldorf and Frankfurt and spent a one-year secondment at Davis Polk Wardwell LLP in Menlo Park/USA working mainly on technology related capital markets transactions.
Arne publishes regularly in legal journals. He is a member of the German Association for the Protection of Intellectual Property (GRUR) and of the Pharmaceutical Trade Marks Group (PTMG). And he is fluent in German and English.